The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy.
Saved in:
| Title: | The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy. |
|---|---|
| Authors: | Wang N; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Sun Q; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Novak D; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Zhu L; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.; JCCU Translational Surgical Oncology (A430), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Poelchen J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Steinfass T; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Wang Y; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany., Umansky V; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.; Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany. |
| Source: | Molecular oncology [Mol Oncol] 2026 May; Vol. 20 (5), pp. 1185-1201. Date of Electronic Publication: 2025 Oct 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41044875 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+N%22">Wang N</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Sun+Q%22">Sun Q</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Novak+D%22">Novak D</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Zhu+L%22">Zhu L</searchLink>; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.; JCCU Translational Surgical Oncology (A430), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Poelchen+J%22">Poelchen J</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Steinfass+T%22">Steinfass T</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Umansky+V%22">Umansky V</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany.; Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Utikal+J%22">Utikal J</searchLink>; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2026 May; Vol. 20 (5), pp. 1185-1201. <i>Date of Electronic Publication: </i>2025 Oct 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41044875 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.70137 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1185 Titles: – TitleFull: The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang N – PersonEntity: Name: NameFull: Sun Q – PersonEntity: Name: NameFull: Novak D – PersonEntity: Name: NameFull: Zhu L – PersonEntity: Name: NameFull: Poelchen J – PersonEntity: Name: NameFull: Steinfass T – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Umansky V – PersonEntity: Name: NameFull: Utikal J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1878-0261 Numbering: – Type: volume Value: 20 – Type: issue Value: 5 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |